MediThinQ Secures $8.6M Series B Funding to Revolutionize Surgical Imaging and Ergonomics

MediThinQ is excited to announce a remarkable milestone in its journey, having successfully raised ₩8,600,000, a significant investment that underscores the growing confidence in our innovative approach and advanced technologies in the medical imaging field. Founded in November 2018 and based in the dynamic Pangyo Techno Valley in South Korea, MediThinQ has quickly made its mark by developing and manufacturing state-of-the-art medical imaging equipment. Our flagship products, SCOPEYE and MetaSCOPE, have been designed to provide surgeons with a revolutionary surgical viewing experience, enabling them to move freely during long, complex operations without compromising on performance or precision. This funding injection will be strategically utilized to accelerate the continued development of our cutting-edge imaging technologies and to support clinical research initiatives aimed at enhancing image clarity and operational ergonomics. Having already garnered recognition as the winners of the Medronic APAC Innovation Challenge 2022, the company is committed to expanding its R&D efforts to further innovate and tailor our solutions to meet the evolving needs of modern surgical practices. Our lightweight, comfortable, and ergonomically sound solutions not only empower surgeons with greater mobility and clearer visualizations during intricate procedures but also contribute to improved patient outcomes by offering enhanced performance in challenging surgical environments. The new funds will also bolster our capacity to scale production, ensuring that our advanced imaging solutions are accessible to a wider range of healthcare providers, and reinforcing MediThinQ’s position as a leader in medical innovation. We look forward to a future of continued growth and innovation, driven by our unwavering commitment to improving surgical experiences and outcomes worldwide.